About this trial
Each form of intellectual disability under study is a rare disease in its own right, and it is therefore difficult to study the variability of its expression. It therefore appears necessary to study large series of patients with intellectual disabilities. The objective is to identify variants in phenotype-modifying genes in patients with intellectual disability.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Patients with Intellectual Disability or related but not affected by them
Major or minor with autorisation of legal representative
Exome sequencing in Bordeaux University Hospital between 2018 and 2024
Disqualifiers
Refusal to participate in research protocols
Refusal to participate expressed following receipt of information letter.
Trial population
Patients with intellectual disabilities or related but not affected by them
Trial design
Case-control
Retrospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Variants in phenotype-modifying genes
Identifying variants in phenotype-modifying genes in patients with intellectual disability.
Secondary outcomes
Phenotypic traits
Correlation phenotypic traits with additional diagnostic variants
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: